Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

306 results found

2021 ∙ Rosamilia, F. Noberasco, G. Olobardi, D. Orsi, A. Icardi, G. Lantieri, F. Murdaca, G.

Flu and pneumococcal vaccine coverage in scleroderma patients still need to be prompted: A systematic review

  • All age groups
  • Influenza
  • Pneumococcal disease
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Wang, L. M. Hashiguchi, T. C. O. Cecchini, M.

Impact of vaccination on carriage of and infection by antibiotic-resistant bacteria: A systematic review and meta-analysis

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Marques Antunes, M. Duarte, G. S. Brito, D. Borges, M. Costa, J. Ferreira, J. J. Pinto, F. J. Caldeira, D.

Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis

  • Adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Zhu, X. Li, X.

Pneumococcal vaccine effect on hospitalisation rates of pneumonia in children: A meta-analysis

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Desalermos, A. Pimienta, M. Kalligeros, M. Shehadeh, F. Diamantopoulos, L. Karamanolis, G. Caldera, F. Farraye, F. A.

Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis

  • Adults
  • Hepatitis B
  • Influenza
  • Herpes zoster
  • Pneumococcal disease
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Bhanu, C. Gopal, D. P. Walters, K. Chaudhry, U. A. R.

Vaccination uptake amongst older adults from minority ethnic backgrounds: A systematic review

  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Diphtheria
  • Pertussis
  • Tetanus
  • Ethical issues
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ SAGE

Considerations for pneumococcal vaccination in older adults

  • SAGE background document
  • Pneumococcal disease
Download:
2021 ∙ SAGE

Pneumococcal vaccines: WHO position paper on their use in community outbreak settings

  • Position paper
  • Pneumococcal disease
Download:
2021 ∙ Conseil Supérieur de la Santé (CSS)

Recommendations for the vaccination of children at increased risk of invasive pneumococcal disease (PID)

  • Recommendation
  • Europe
  • Belgium
  • children
  • Pneumococcal disease
Download:
2020 ∙ Choe, Y. J. Blatt, D. B. Lee, H. J. Choi, E. H.

Associations between geographic region and immune response variations to pneumococcal conjugate vaccines in clinical trials: A systematic review and meta-analysis

  • Newborn
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...